Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04985708 · ClinicalTrials.gov registry record
Carolinas Cardiogenic Shock Initiative
A clinical trial, sponsored by Wake Forest University Health Sciences.
- Completed
- Registry status
- 120
- Enrollment target
NCT04985708 is a clinical trial that has completed, run by Wake Forest University Health Sciences. The registered enrollment target is 120 participants.
The verdict
NCT04985708 has completed, sponsored by Wake Forest University Health Sciences.
- COMPLETED
- Registry status
- 120 participants
- Enrollment target
Study Summary
To determine if deferred or delayed implantation of Impella device based on shock severity index is non-inferior with respect to 1 month and 1 year mortality compared to standard clinical protocols that do not differentiate based on shock severity in adult patients following an initial diagnosis of acute myocardial infarction complicated by cardiogenic shock (AMICS).
Interventions
- OTHER data collection of clinically available procedures
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2019-05-01 |
| Est. Completion | 2022-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04985708
The ClinicalTrials.gov registry entry for NCT04985708 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which data collection of clinically available procedures is the first listed.
NCT04985708 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04985708 about?
NCT04985708 is a clinical study titled "Carolinas Cardiogenic Shock Initiative". To determine if deferred or delayed implantation of Impella device based on shock severity index is non-inferior with respect to 1 month and 1 year mortality compared to standard clinical protocols that do not differentiate based on shock severity in adult patients following an initial diagnosis of ...
What is the current status of trial NCT04985708?
This trial is currently completed. The enrollment target is 120 participants. The study started on 2019-05-01. Estimated completion is 2022-05-31.
What interventions are being tested in trial NCT04985708?
The interventions under investigation include: data collection of clinically available procedures (OTHER).
Who is sponsoring clinical trial NCT04985708?
This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.